Osteoclasts play a part in pain due to the inflammation adjacent to bone

Bone

Volumn 39, Issue 5, 2006, Pages 1107-1115

  Nagae, Maho ^a   Hiraga, Toru ^a   Wakabayashi, Hiroki ^a   Wang, Liyang ^a   Iwata, Koichi ^b   Yoneda, Toshiyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Acid sensing receptors; Bisphosphonates; Hyperalgesia; Osteoclasts; Proton

Indexed keywords

ACID SENSING ION CHANNEL 1A; ACID SENSING ION CHANNEL 1B; ACID SENSING ION CHANNEL 3; ALENDRONIC ACID; BAFILOMYCIN A1; BISPHOSPHONIC ACID DERIVATIVE; FREUND ADJUVANT; ION CHANNEL; MESSENGER RNA; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN C FOS; RECEPTOR SUBUNIT; TRANSIENT RECEPTOR POTENTIAL CHANNEL VANILLOID SUBFAMILY MEMBER 1; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE PAIN; CELL LINE; CELL PH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; MALE; METATARSAL BONE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ANIMALS; BONE AND BONES; BONE RESORPTION; CELL LINE; DIPHOSPHONATES; FREUND'S ADJUVANT; GENES, SRC; HYPERALGESIA; INFLAMMATION; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; MACROLIDES; MALE; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; PAIN; PARATHYROID HORMONE; POSTERIOR HORN CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM CHANNELS; TRPV CATION CHANNELS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 33749536383     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.04.033     Document Type: Article

References (45)

1. Fulfaro F., Casuccio A., Ticozzi C., and Ripamonti C. The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78 (1998) 157-169
2. Adami S., Bevilacqua M., Broggini M., Filipponi P., Ortolani S., Palummeri E., et al. Short-term intravenous therapy with neridronate in Paget's disease. Clin. Exp. Rheumatol. 20 (2002) 55-58
3. Gangji V., and Appelboom T. Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin. Rheumatol. 18 (1999) 266-267
4. Lane J.M., Khan S.N., O'Connor W.J., Nydick M., Hommen J.P., Schneider R., et al. Bisphosphonate therapy in fibrous dysplasia. Clin. Orthop. 382 (2001) 6-12
5. Astrom E., and Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch. Dis. Child 86 (2002) 356-364
6. Rovetta G., and Monteforte P. Efficacy of disodium-clodronate in the management of joint pain in rheumatoid arthritis. Six month open study. Minerva Med. 94 (2003) 353-357
7. Walsh N.C., and Gravallese E.M. Bone loss in inflammatory arthritis: mechanism and treatment strategies. Curr. Opin. Rheumatol. 16 (2004) 419-427
8. Gennari C., Agnusdei D., and Camporeale A. Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif. Tissue Int. 49 (1991) S9-S13
9. Davies J., Trask C., and Souhami R.L. Effect of mithramycin on widespread painful bone metastases in cancer of the breast. Cancer Treat Rep. 63 (1979) 1835-1838
10. Warrell Jr. R.P. Gallium nitrate for the treatment of bone metastases. Cancer 80 (1997) 1680-1685
11. Ren K., and Dubner R. Inflammatory models of pain and hyperalgesia. ILAR J. 40 (1999) 111-118
12. Stein C., Millan M.J., and Nerz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol. Biochem. Behav. 31 (1988) 445-451
13. Haynes L., Eaton S.M., Burns E.M., Rincon M., and Swain S.L. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J. Immunol. 172 (2004) 5194-5199
14. Spears R., Dees L.A., Sapozhnikov M., Bellinger L.L., and Hutchins B.T. Temporal changes in inflammatory mediator concentrations in an adjuvant model of temporomandibular joint inflammation. J. Orofac. Pain 19 (2005) 34-40
15. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
16. Rousselle A.V., and Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 30 (2002) 533-540
17. Reeh P.W., and Kress M. Molecular physiology of proton transduction in nociceptors. Curr. Opin. Pharmacol. 1 (2001) 45-51
18. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
19. Mantyh P.W., Clohisy D.R., Koltzenburg M., and Hunt S. Molecular mechanism of cancer pain. Nature Rev. Cancer 2 (2002) 201-209
20. Mach D.B., Rogers S.D., Sabino M.C., Luger N.M., Schwei M.J., Pomonis J.D., et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113 (2002) 155-166
21. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
22. Ren K., Blass E.M., Zhou Q., and Dubner R. Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1471-1475
23. Lao L., Zhang R.X., Zhang G., Wang X., Berman B.M., and Ren K. A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats. Brain Res. 1020 (2004) 18-29
24. Hunt S.P., Pini A., and Evan G. Induction of Fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
25. Bullitt E. Expression of c-Fos-like protein as a marker for neural activity following noxious stimulation in the rat. J. Comp. Neurol. 296 (1990) 517-530
26. Iwata K., Takahashi O., Tsuboi Y., Ochiai H., Hibiya J., Sasaki T., et al. Fos protein induction in the medullary dorsal horn and first segment of the spinal cord by tooth-pulp stimulation in cats. Pain 75 (1998) 27-36
27. 1 abolishes bone resorption. Biochem. Biophys. Res. Commun. 168 (1990) 309-313
28. Platika D., Boulos M.H., Baizer L., and Fishman M.C. Neural traits of clonal cell line derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 3499-3503
29. Francel P.C., Harris K., Smith M., Fishman M.C., Dawson G., and Miller R.J. Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J. Neurochem. 48 (1987) 1624-1631
30. Iwata K., Tashiro A., Tsuboi Y., Imai T., Sumino R., Morimoto T., et al. Medullary dorsal horn neuronal activity in rats with persistent temporomandibular joint and perioral inflammation. J. Neurophysiol. 82 (1999) 1244-1253
31. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
32. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
33. Honore P., Luger N.M., Sabino M.A.C., Schwei M., Rogers S.D., Mach D.B., et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 6 (2000) 521-528
34. Ohnishi T., Takeda E., Yogita S., Miyake H., Kinoshita T., Terashima Y., et al. Effects of alendronate on bone metastases and hypercalcemia after surgery for hepatocellular carcinoma. Jpn. J. Clin. Oncol. 30 (2000) 410-413
35. Rosen L.S., Gordon D., Antonio B.S., Kaminski M., Howell A., Belch A., et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 7 (2001) 377-387
36. Yates A.J.P., Gutierrez G.E., Smolens P., Travis P.S., Katz M.S., Aufdemorte T.B., et al. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J. Clin. Invest. 81 (1988) 932-938
37. Hiraga T., Myoui A., Choi M.E., Yoshikawa H., and Yoneda T. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor β enhances bone metastases in breast cancer. Cancer Res. 66 (2006) 2067-2073
38. Voilley N., de Wille J., Mamet J., and Lazdunski M. Non-steroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced suppression of acid-sensing ion channels in nociceptors. J. Neurosci. 21 (2001) 8026-8033
39. Ikeda F., Nishimura R., Matsubara T., Tanaka S., Inoue J., Reddy S.V., et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114 (2004) 475-484
40. Boyce B.F., Yoneda T., Lowe C., Soriano P., and Mundy G.R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90 (1992) 1622-1627
41. Lowe C., Yoneda T., Boyce B.F., Chen H., Mundy G.R., and Soriano P. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4485-4489
42. Jahnel R., Bender O., Munter L.M., Dreger M., Gillen C., and Hucho F. Dual expression of mouse and rat VRL-1 in the dorsal root ganglion derived cell line F-11 and biochemical analysis of VRL-1 after heterologous expression. Eur. J. Biochem. 270 (2003) 4264-4271
43. Krishtal O. The ASICs: signaling molecules? Modulators?. Trends Neurosci. 26 (2003) 477-483
44. Van Offel J.F., Dombrecht E.J., Bridts C.H., Schuerwegh A.J., Ebo D.G., Stevens W.J., and De Clerck L.S. Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes. Cytokine 31 (2005) 298-304
45. Mercadante M. Malignant bone pain: pathophysiology and treatment. Pain 69 (1997) 1-18